Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function - PubMed (original) (raw)

Randomized Controlled Trial

. 2006 Nov;152(5):975.e9-15.

doi: 10.1016/j.ahj.2006.08.004.

Jirí Mayer, Ladislav Groch, Stanislav Janousek, Ivan Hornácek, Ota Hlinomaz, Petr Kala, Roman Panovský, Jirí Prásek, Milan Kamínek, Jaroslav Stanícek, Martin Klabusay, Zdenik Korístek, Milan Navrátil, Ladislav Dusek, Jaroslava Vinklárková

Affiliations

• PMID: 17070173
• DOI: 10.1016/j.ahj.2006.08.004

Randomized Controlled Trial

Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function

Jaroslav Meluzín et al. Am Heart J. 2006 Nov.

Abstract

Background: Despite the reports on successful treatment of acute myocardial infarction using autologous mononuclear bone marrow cell transplantation, many unresolved questions still remain. We studied the impact of the dose of transplanted cells on myocardial function and perfusion.

Methods: Sixty-six patients with a first acute myocardial infarction were randomized into 3 groups. Two groups were intracoronarily given mononuclear bone marrow cells in either higher (10(8) cells, higher cell dose [HD] group, n = 22) or lower (10(7) cells, lower cell dose [LD] group, n = 22) doses. Twenty-two patients without cell transplantation served as a control (C) group.

Results: At 3 months of follow-up, the baseline peak systolic velocities of longitudinal contraction of the infarcted wall of 5.2, 4.5, and 4.3 cm/s in C, LD, and HD groups increased by 0.0, 0.5 (P < .05 vs C group), and 0.9 cm/s (P < .05 vs LD group, P < .01 vs C group), respectively, as demonstrated by Doppler tissue imaging. Baseline left ventricular ejection fractions of 42%, 42%, and 41% in C, LD, and HD groups increased by 2%, 3%, and by 5% (P < .05 vs group C), respectively, as assessed by the gated technetium Tc 99m sestamibi single photon emission computed tomography.

Conclusions: Mononuclear bone marrow cell transplantation improves regional myocardial function of the infarcted wall in a dose-dependent manner.

PubMed Disclaimer

Similar articles

• Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction.
  Meluzín J, Janousek S, Mayer J, Groch L, Hornácek I, Hlinomaz O, Kala P, Panovský R, Prásek J, Kamínek M, Stanícek J, Klabusay M, Korístek Z, Navrátil M, Dusek L, Vinklárková J. Meluzín J, et al. Int J Cardiol. 2008 Aug 18;128(2):185-92. doi: 10.1016/j.ijcard.2007.04.098. Epub 2007 Aug 30. Int J Cardiol. 2008. PMID: 17764767 Clinical Trial.
• Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.
  Chen SL, Fang WW, Qian J, Ye F, Liu YH, Shan SJ, Zhang JJ, Lin S, Liao LM, Zhao RC. Chen SL, et al. Chin Med J (Engl). 2004 Oct;117(10):1443-8. Chin Med J (Engl). 2004. PMID: 15498362 Clinical Trial.
• [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
  Huang RC, Yao K, Zou YZ, Ge L, Qian JY, Yang J, Yang S, Niu YH, Li YL, Zhang YQ, Zhang F, Xu SK, Zhang SH, Sun AJ, Ge JB. Huang RC, et al. Zhonghua Yi Xue Za Zhi. 2006 Apr 25;86(16):1107-10. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16796836 Clinical Trial. Chinese.
• Autologous bone marrow stem cell transplantation in acute myocardial infarction-report of two cases.
  Siminiak T, Grygielska B, Jerzykowska O, Fiszer D, Kałmucki P, Rzeźniczak J, Kurpisz M. Siminiak T, et al. Kardiol Pol. 2003 Dec;59(12):502-10. Kardiol Pol. 2003. PMID: 14724697 Review.
• Bone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questions.
  Dai W, Kloner RA. Dai W, et al. Am J Transplant. 2011 Nov;11(11):2297-301. doi: 10.1111/j.1600-6143.2011.03750.x. Epub 2011 Sep 19. Am J Transplant. 2011. PMID: 21929617 Review.

Cited by

• Cell therapy for acute myocardial infarction--where do we go from here?
  Traverse JH, Henry TD. Traverse JH, et al. J Cardiovasc Transl Res. 2008 Mar;1(1):64-70. doi: 10.1007/s12265-007-9002-0. Epub 2008 Jan 31. J Cardiovasc Transl Res. 2008. PMID: 20559959 Review.
• Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease.
  Boudoulas KD, Hatzopoulos AK. Boudoulas KD, et al. Dis Model Mech. 2009 Jul-Aug;2(7-8):344-58. doi: 10.1242/dmm.000240. Dis Model Mech. 2009. PMID: 19553696 Free PMC article. Review.
• A dosing study of bone marrow mononuclear cells for transendocardial injection in a pig model of chronic ischemic heart disease.
  Silva GV, Fernandes MR, Cardoso CO, Sanz RR, Oliveira EM, Jimenez-Quevedo P, Lopez J, Angeli FS, Zheng Y, Willerson JT, Perin EC. Silva GV, et al. Tex Heart Inst J. 2011;38(3):219-24. Tex Heart Inst J. 2011. PMID: 21720456 Free PMC article.
• Cell therapy for myocardial infarction.
  Kwon YW, Yang HM, Cho HJ. Kwon YW, et al. Int J Stem Cells. 2010 May;3(1):8-15. doi: 10.15283/ijsc.2010.3.1.8. Int J Stem Cells. 2010. PMID: 24855535 Free PMC article.
• Current stem cell delivery methods for myocardial repair.
  Sheng CC, Zhou L, Hao J. Sheng CC, et al. Biomed Res Int. 2013;2013:547902. doi: 10.1155/2013/547902. Epub 2012 Dec 27. Biomed Res Int. 2013. PMID: 23509740 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program